MedPath

Comparing the Efficacy of Aripiprazole with other Second-Generation Antipsychotics in smoke cessation of inpatient Manic sufferers

Phase 4
Conditions
Condition 1: Bipolar mood disorder. Condition 2: Nicotine dependence.
Persistent mood [affective] disorders
Nicotine dependence
Registration Number
IRCT20181026041468N1
Lead Sponsor
Arak University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
40
Inclusion Criteria

Bipolar disorder type-I patients in manic phase
older than 18
Informed consent

Exclusion Criteria

Use of anti-psychotic medicines during the recent past 30 days
Use of ECT during the recent past 6 months
Pregnancy or breast-feeding
Alcohol dependence
Psychiatric disorders other than bipolar disorder
High risk of suicide
The use of mood stabilizers other than sodium valproate
liver disease
Positive history of polycystic ovaries
Thrombocytopenia

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
icotine dependence. Timepoint: 0, 1, 2, 4, 6 weeks. Method of measurement: Nicotine Dependence Syndrome Scale (NDSS).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath